Jen Maki, Ph.D.

Jen Maki, Ph.D. concentrates her work on commercial due diligence, strategy formulation, and the analysis and modeling of factors that drive demand for products and services. Dr. Maki’s clients include private equity funds, investment banks, legal counsel, service providers, and product manufacturers.

Dr. Maki frequently works with various data including client, third party, and publicly available data to assess demand for products, market growth rates, the competitive landscape, price and price variation, and to evaluate usage patterns. Her dual background in economics and accounting enables her to apply both economic theory and financial analysis to isolate and quantify the impact from events.

Dr. Maki regularly provides litigation support and has served as a testifying expert on cases ranging across sectors including technology, healthcare, and sports and apparel. She provides context and clarity to complex situations by refining data and analysis from disparate sources to provide clear and compelling narratives.

Dr. Maki is an active researcher and has written on topics including the effects of informational interventions on individual decision-making; digital health and issues related to cost-effectiveness, utilization, and equity; and on public policies and their impact on individual behavior. Her research articles have been published in peer reviewed journals, including the Southern Economic Journal and the International Journal of Drug Policy. She also holds a position as an Academic Associate at Arizona State University and teaches a graduate-level economics course.

Relevant Experience:

• Engaged by an investment bank to conduct a vendor due diligence assessment for a large multinational foreign aid contracting firm. This project included a comprehensive market assessment spanning the U.S., UK and Australia, a competitive landscape analysis, and an assessment of the company's competitive advantage.
• Engaged by a private equity fund to conduct a market and competitive landscape assessment for a media company. The project included an assessment of the short and long-term impacts of COVID-19, potential regulatory changes related to the new Biden administration, a review of current customers and purchasing behavior to assess threats to revenue, and an overview of firms in adjacencies.
• Engaged by a telecom company to assess marketplace stability and identify opportunities, by market segment, for expansion; evaluate the competitive landscape and conduct a scan for potential strategic partnerships.
• Created the framework and conducted the analysis to assess market attractiveness and identify which countries the firm should grow, optimize, or harvest and exit for a private equity firm purchasing a major medical product manufacturer; conducted a profitability study to assess true product-level profitability, identify avoidable costs and quantify return on investment.
• Engaged by an IVD manufacturer to perform commercial due diligence as they evaluated targets for cross-border M&A. Performed IVD market sizing (including life science) by technology, application and end customer type. Assessed competitive landscape and identified relative strengths and weaknesses of players in the space. Identified potential synergy realization related to the target and several other candidates for acquisition.